[{"address1": "1901 West 47th Place", "city": "Kansas City", "state": "KS", "zip": "66205", "country": "United States", "phone": "913 942 2300", "website": "https://www.cingulate.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cingulate Inc., a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company's stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults. It also focuses on developing CTx-2103 that is in a formulation stage for the treatment of anxiety. The company was founded in 2012 and is headquartered in Kansas City, Kansas.", "fullTimeEmployees": 13, "companyOfficers": [{"maxAge": 1, "name": "Dr. Shane J. Schaffer Pharm.D.", "age": 48, "title": "CEO & Chairman of the Board", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 491961, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Laurie A. Myers M.B.A., Ph.D.", "age": 66, "title": "Executive VP & COO", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 415167, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew N. Brams M.D.", "age": 59, "title": "Executive VP & Chief Medical Officer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 244792, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jennifer L. Callahan CPA", "age": 52, "title": "Senior VP, CFO & Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Raul R. Silva M.D.", "age": 65, "title": "Executive VP & Chief Science Officer", "yearBorn": 1958, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Thomas  Dalton", "title": "Vice President of Investor & Public Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.44, "open": 3.29, "dayLow": 3.29, "dayHigh": 3.57, "regularMarketPreviousClose": 3.44, "regularMarketOpen": 3.29, "regularMarketDayLow": 3.29, "regularMarketDayHigh": 3.57, "forwardPE": -0.4746922, "volume": 136594, "regularMarketVolume": 136594, "averageVolume": 3920050, "averageVolume10days": 232410, "averageDailyVolume10Day": 232410, "bid": 3.44, "ask": 3.55, "bidSize": 100, "askSize": 100, "marketCap": 10563270, "fiftyTwoWeekLow": 1.8, "fiftyTwoWeekHigh": 152.4, "fiftyDayAverage": 4.9086, "twoHundredDayAverage": 9.21992, "currency": "USD", "enterpriseValue": -3676698, "floatShares": 1761081, "sharesOutstanding": 3044160, "sharesShort": 38266, "sharesShortPriorMonth": 108760, "sharesShortPreviousMonthDate": 1726185600, "dateShortInterest": 1728950400, "sharesPercentSharesOut": 0.0126, "heldPercentInsiders": 0.033, "heldPercentInstitutions": 0.0256, "shortRatio": 0.23, "shortPercentOfFloat": 0.012999999, "impliedSharesOutstanding": 3044170, "bookValue": 6.815, "priceToBook": 0.50917095, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -16348455, "trailingEps": -326.4, "forwardEps": -7.31, "lastSplitFactor": "1:12", "lastSplitDate": 1723161600, "enterpriseToEbitda": 0.236, "52WeekChange": -0.9533602, "SandP52WeekChange": 0.35905516, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "CING", "underlyingSymbol": "CING", "shortName": "Cingulate Inc.", "longName": "Cingulate Inc.", "firstTradeDateEpochUtc": 1638973800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bf898f9d-c1c1-3f31-9c96-a5b2c0f73dcd", "messageBoardId": "finmb_1674914781", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.47, "targetHighPrice": 96.0, "targetLowPrice": 70.0, "targetMeanPrice": 80.33, "targetMedianPrice": 75.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 10040149, "totalCashPerShare": 5.684, "ebitda": -15568522, "totalDebt": 234174, "quickRatio": 6.51, "currentRatio": 7.354, "debtToEquity": 1.945, "returnOnAssets": -1.04327, "returnOnEquity": -2.7381501, "freeCashflow": -10794803, "operatingCashflow": -16934228, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-11-11"}]